Alivus Life Sciences Stock Forecast

Buy or Hold candidate since Jul 31, 2026 Gain 20.14%

The Alivus Life Sciences Ltd. stock price gained 1.39% on the last trading day (Tuesday, 11th Aug 2026), rising from ₹1,374.50 to ₹1,393.60. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 3.18% from a day low at ₹1,374.30 to a day high of ₹1,418.00. The price has risen in 7 of the last 10 days and is up by 26.15% over the past 2 weeks. Volume fell on the last day by -154 thousand shares and in total, 189 thousand shares were bought and sold for approximately ₹263.25 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock has broken the wide and strong rising the short-term trend up and an even stronger rate of rising is indicated. For any reaction back there will now be support on the roof on the current trend broken at ₹1,284.72, a level that may pose a second chance to hit a runner. According to fan-theory ₹1,443.90 will be the next possible trend-top level and thereby pose a resistance level that may not be broken at the first attempt.

ALIVUS.NS Signals & Forecast

The Alivus Life Sciences Ltd. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at ₹1,329.19 and ₹1,175.36. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Thursday, July 30, 2026, and so far it has risen 27.19%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely.

Support, Risk & Stop-loss for Alivus Life Sciences Ltd. stock

Alivus Life Sciences Ltd. finds support from accumulated volume at ₹1,374.50 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved ₹43.70 between high and low, or 3.18%. For the last week, the stock has had daily average volatility of 3.37%.

The Alivus Life Sciences Ltd. stock is extremely overbought on RSI14 (78). Normally this may pose a good selling opportunity but since the stock has broken the trend up, the chance for a major correction due to high RSI is very small as the stock will find support at the trend broken.

Our recommended stop-loss: ₹1,352.63 (-2.94%) (This stock has high daily movements and this gives high risk. The RSI14 is 78 and this increases the risk substantially. There is a buy signal from a pivot bottom found 8 days ago.)

Trading Expectations (ALIVUS.NS) For The Upcoming Trading Day Of Wednesday 12th

For the upcoming trading day on Wednesday, 12th we expect Alivus Life Sciences Ltd. to open at ₹1,395.30, and during the day (based on 14 day Average True Range), to move between ₹1,369.37 and ₹1,417.83, which gives a possible trading interval of +/-₹48.46 (+/-3.54%) up or down from last closing price. If Alivus Life Sciences Ltd. takes out the full calculated possible swing range there will be an estimated 3.54% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ ₹1,374.50, some ₹19.10 (1.37%) from the current price of ₹1,393.60, our system finds the risk reward attractive.

Dividend Warning For ALIVUS.NS

Dividend coming up for ALIVUS.NS: Ex-dividend date (Tuesday 1st September, 2026) is 20 days away. The dividend is ₹5.00.

Is Alivus Life Sciences Ltd. stock A Buy?

Alivus Life Sciences Ltd. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Strong Buy to a Hold candidate.

Current score: 0.000 Hold/Accumulate Downgraded

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Fair Opening Price

Predicted fair opening price on August 12, 2026 - ₹1,395.30 ( 0.122%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk